ROMEO, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 4.096
AS - Asia 2.706
EU - Europa 1.088
SA - Sud America 679
AF - Africa 67
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 10
Totale 8.656
Nazione #
US - Stati Uniti d'America 3.940
SG - Singapore 1.173
CN - Cina 537
BR - Brasile 512
IT - Italia 431
VN - Vietnam 325
IN - India 310
GB - Regno Unito 138
SE - Svezia 137
DE - Germania 119
CA - Canada 106
HK - Hong Kong 103
AR - Argentina 65
FI - Finlandia 57
NL - Olanda 33
PK - Pakistan 33
EC - Ecuador 31
BD - Bangladesh 30
MX - Messico 30
IQ - Iraq 29
ID - Indonesia 27
JP - Giappone 25
TR - Turchia 25
ES - Italia 24
FR - Francia 24
RU - Federazione Russa 22
EG - Egitto 21
CO - Colombia 16
CZ - Repubblica Ceca 16
PL - Polonia 16
VE - Venezuela 16
ZA - Sudafrica 15
CL - Cile 14
KR - Corea 14
AT - Austria 13
SA - Arabia Saudita 12
AE - Emirati Arabi Uniti 11
UY - Uruguay 10
AU - Australia 9
NO - Norvegia 9
PY - Paraguay 9
DZ - Algeria 7
RO - Romania 7
TW - Taiwan 7
UA - Ucraina 7
EU - Europa 6
IR - Iran 6
JM - Giamaica 6
KE - Kenya 6
MA - Marocco 6
NP - Nepal 5
UZ - Uzbekistan 5
GR - Grecia 4
IL - Israele 4
KG - Kirghizistan 4
PE - Perù 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BG - Bulgaria 3
CH - Svizzera 3
CR - Costa Rica 3
EE - Estonia 3
ET - Etiopia 3
JO - Giordania 3
MY - Malesia 3
PT - Portogallo 3
SI - Slovenia 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AL - Albania 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
IE - Irlanda 2
KZ - Kazakistan 2
LB - Libano 2
LT - Lituania 2
LY - Libia 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
AM - Armenia 1
BB - Barbados 1
BY - Bielorussia 1
DJ - Gibuti 1
GT - Guatemala 1
KH - Cambogia 1
LV - Lettonia 1
MD - Moldavia 1
MR - Mauritania 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RS - Serbia 1
SC - Seychelles 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
Totale 8.655
Città #
San Jose 786
Chandler 472
Singapore 389
Ashburn 364
Dallas 228
Santa Clara 217
Bengaluru 194
Hefei 194
Milan 149
Princeton 143
Lawrence 142
Ho Chi Minh City 141
Hong Kong 95
London 94
Chicago 92
Beijing 84
Munich 84
Wilmington 70
Hanoi 68
Ottawa 61
Des Moines 57
Boardman 43
São Paulo 43
Catanzaro 38
Turku 37
New York 30
Göteborg 29
Los Angeles 29
Redwood City 25
Orem 22
Chennai 19
Helsinki 18
Pune 18
Rome 18
Council Bluffs 17
Rio de Janeiro 17
Amsterdam 15
Warsaw 15
Norwalk 14
Phoenix 14
San Francisco 14
Guangzhou 13
Olomouc 13
Toronto 13
Guayaquil 12
Haiphong 12
Mexico City 12
Secaucus 11
The Dalles 11
Brooklyn 10
Palermo 10
Redmond 10
Thái Bình 10
Baghdad 9
Columbus 9
Curitiba 9
Hải Dương 9
Kochi 9
Montevideo 9
Montreal 9
Mumbai 9
Porto Alegre 9
Shanghai 9
Tokyo 9
Buenos Aires 8
Guarulhos 8
Istanbul 8
Lahore 8
Quito 8
Stockholm 8
Voghera 8
West Jordan 8
Aversa 7
Belo Horizonte 7
Buffalo 7
Da Nang 7
Erbil 7
Florence 7
Naples 7
Biên Hòa 6
Brasília 6
Campinas 6
Dhaka 6
Ha Long 6
Johannesburg 6
Manaus 6
Nairobi 6
New Delhi 6
Sydney 6
São Bernardo do Campo 6
Asunción 5
Atlanta 5
Cairo 5
Delhi 5
Duque de Caxias 5
Fuzhou 5
Hyderabad 5
Islamabad 5
Jeddah 5
Jiaxing 5
Totale 5.064
Nome #
Genetics and epigenetics of NAFLD and NASH: Clinical impact 402
A Rapid and Cheap Method for Extracting and Quantifying Lycopene Content in Tomato Sauces: Effects of Lycopene Micellar Delivery on Human Osteoblast-like Cells 137
Bergamot Polyphenol Extract Reduces Hepatocyte Neutral Fat by Increasing Beta-Oxidation 82
Lycopene and bone: An in vitro investigation and a pilot prospective clinical study 82
Dietary Patterns and Fractures Risk in the Elderly 80
Effect of the replacement of dietary vegetable oils with a low dose of extravirgin olive oil in the Mediterranean Diet on cognitive functions in the elderly 77
Bergamot Polyphenol Fraction Exerts Effects on Bone Biology by Activating ERK 1/2 and Wnt/-Catenin Pathway and Regulating Bone Biomarkers in Bone Cell Cultures 77
Preventing muscle wasting: pro-insulin C-peptide prevents loss in muscle mass in streptozotocin-diabetic rats 76
The IRS1 rs2943641 Variant and Risk of Future Cancer Among Morbidly Obese Individuals 75
Altered Glucose Homeostasis Is Associated with Increased Serum Apelin Levels in Type 2 Diabetes Mellitus 73
Association between low C-peptide and fragility fractures in postmenopausal women without diabetes 72
Effects of C-Peptide Replacement Therapy on Bone Microarchitecture Parameters in Streptozotocin-Diabetic Rats 71
ANGPTL4 gene E40K variation protects against obesity-associated dyslipidemia in participants with obesity. 69
Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery 67
Nutritional parameters predicting pressure ulcers and short-term mortality in patients with minimal conscious state as a result of traumatic and non-traumatic acquired brain injury 67
Carotid intima-media thickness: A target or a Marker? 67
Lipid oxidation assessed by indirect calorimetry predicts metabolic syndrome and type 2 diabetes 67
The potential role of C-peptide in sexual and reproductive functions in type 1 diabetes mellitus: An update 67
High Vegetable Fats Intake Is Associated with High Resting Energy Expenditure in Vegetarians 66
Gender difference in handgrip strength of Italian children aged 9 to 10 years 65
The link between nutritional parameters and bone mineral density in women: results of a screening programme for osteoporosis 65
A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease 64
Association Between the PNPLA3 (rs738409 C > G) Variant and Hepatocellular Carcinoma: Evidence From a Meta-Analysis of Individual Participant Data 64
Inborn and acquired risk factors for severe liver disease in Europeans with type 2 diabetes from the UK Biobank 64
Analysis of TBC1D4 in patients with severe insulin resistance 63
Protein and vitamin B6 intake are associated with liver steatosis assessed by transient elastography, especially in obese individuals 63
Effects of a Functional Ice Cream Enriched with Milk Proteins on Bone Metabolism: A Feasibility Clinical Study and In Vitro Investigation 62
Hemp Seeds in Post-Arthroplasty Rehabilitation: A Pilot Clinical Study and an In Vitro Investigation 62
A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores 61
Effect of a novel functional tomato sauce (OsteoCol) from vine-ripened tomatoes on serum lipids in individuals with common hypercholesterolemia: tomato sauce and hypercholesterolemia 61
Exome-wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated with Fatty Liver Disease 60
Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease. 60
Brachial artery diameter measurement: a tool to simplify non-invasive vascular assessment. 59
The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids 58
Human Multilineage 3D Spheroids as a Model of Liver Steatosis and Fibrosis 57
Global multi-stakeholder endorsement of the MAFLD definition 57
). Unravelling the pathogenesis of fatty liver disease: patatin-like phosholipase domain-ontaining 3 protein 57
Molecular analysis of three known and one novel LPL variants in patients with type I hyperlipoproteinemia 57
Weight Gain and Liver Steatosis in Patients with Inflammatory Bowel Diseases 57
ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization 56
Fat utilization and arterial hypertension in overweight/obese subjects 56
Individuals with Metabolically Healthy Overweight/Obesity Have Higher Fat Utilization than Metabolically Unhealthy Individuals 56
An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans 55
Cardiovascular events after bariatric surgery in obese subjects with type 2 diabetes 55
Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice 55
Bending Resistance at Hip and Fractures Risk in Postmenopausal Women Independent of Bone Mineral Density 55
The COBLL1 C allele is associated with lower serum insulin levels and lower insulin resistance in overweight and obese children 54
PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes. 54
Virtual genetic diagnosis for familial hypercholesterolemia powered by machine learning 54
Disease-specific eQTL screening reveals an anti-fibrotic effect of AGXT2 in non-alcoholic fatty liver disease 53
Alcohol consumption and alcohol problems after bariatric surgery in the swedish obese subjects study 53
The effect of the TM6SF2 E167K variant on liver steatosis and fibrosis in patients with chronic hepatitis C: a meta-analysis 53
DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection 52
Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease 51
Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker. 51
Rare ATG7 genetic variants predispose patients to severe fatty liver disease 50
The rs2294918 K434E PNPLA3 Polymorphism is associated with Nonalcoholic Fatty Liver and Steatohepatitis 50
Hepatocellular carcinoma in nonalcoholic fatty liver: Role of environmental and genetic factors 50
ssociation of MBOAT7 gene variant with plasma ALT levels in children: the PANIC study 50
A case of severe occult ectopic adrenocorticotropin syndrome treated with retrograde venous adrenal ablation using ethanol 50
Impact of PNPLA3 (rs738409 C > G) variant in hepatocellular carcinoma: evidence from a meta-analysis 50
PCSK9 rs11591147 R46L Loss-of-Function Variant Protects Against Liver Damage in Individuals with NAFLD 50
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores 50
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent. 50
Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank 49
The PNPLA3 148M allele (rs738409) is associated with indices of liver damage early in life 49
Nutrients utilization in obese individuals with and without hypertriglyceridemia. 49
Proinsulin C-peptide modulates the expression of ERK1/2, type I collagen and RANKL in human osteoblast-like cells (Saos-2) 49
MBOAT7 is anchored to endomembranes by six transmembrane domains. 49
Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease 47
No Association between polymorphism in PEMT (V175M) and hepatic triglyceride content in the Dallas Heart Study 47
Genetic study of common variants at the Apo E, Apo AI, Apo CIII, Apo B, lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes and coronary artery disease (CAD): variation in LIPC gene associates with clinical outcomes in patients with established CAD 47
Association of FTO polymorphisms with early age of obesity in obese Italian subjects 47
The PNPLA3 Ile148Met interacts with overweight and dietary intakes on fasting triglyceride levels 47
The rs2294918 E434K variant modulates patatin‐like phospholipase domain‐containing 3 expression and liver damage 47
Statin use and non-alcoholic steatohepatitis in at risk individuals 47
IL32 downregulation lowers triglycerides and type I collagen in di-lineage human primary liver organoids 46
Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease 46
MODY-like diabetes associated with an apparently balanced translocation: possible involvement of MPP7 gene and cell polarity in the pathogenesis of diabetes 46
The 3′-UTR C > T polymorphism of the oxidized LDL-receptor 1 (OLR1) gene does not associate with coronary artery disease in Italian CAD patients or with the severity of coronary disease 46
Down-regulation of hepatic MBOAT7 by hyperinsulinemia favors steatosis development 46
Association between low C-peptide and low lumbar bone mineral density in postmenopausal women without diabetes 46
Predictors of controlled attenuation parameter in metabolic dysfunction 45
Effect of excess body weight on the genetic susceptibility to cancer. 45
The G972R variant of the insulin receptor substrate-1 gene impairs insulin signaling and cell differentiation in 3T3L1 adipocytes; treatment with a PPARγ agonist restores normal cell signalling and differentiation 45
Carotid and brachial arterial enlargement in postmenopausal women with hypertension 45
Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis 45
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol 44
Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): Beyond insulin resistance 44
3D culture models to study pathophysiology of steatotic liver disease 44
The G972R variant of the insulin receptor substrate-1 (IRS-1) gene is associated with insulin resistance in "uncomplicated" obese subjects evaluated by hyperinsulinemic-euglycemic clamp 44
Pnpla3 Silencing with Antisense Oligonucleotides Ameliorates Nonalcoholic Steatohepatitis and Fibrosis in Pnpla3 I148M Knock-in Mice 44
Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease 43
PSD3 downregulation confers protection against fatty liver disease 43
Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL 43
Continuous glucose monitoring during the European Soccer cup semifinal, Italy against Holland 43
Transmembrane-6 superfamily member 2 (TM6SF2) E167K variant increases susceptibility to hepatic steatosis in obese children 43
Type 1 hyperlipoproteinemia due to a novel deletion of exons 3 and 4 in the GPIHBP1 gene 43
Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patients 43
Effects of PNPLA3 I148M on hepatic lipid and very-low-density lipoprotein metabolism in humans 42
Totale 5.941
Categoria #
all - tutte 78.700
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.700


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 0 0 0 0 0 0 0 0 0 2 7
2021/2022409 12 6 11 58 47 9 15 79 39 49 81 3
2022/20231.372 286 38 55 110 181 118 18 113 232 88 100 33
2023/2024671 146 75 62 37 28 133 30 28 19 26 33 54
2024/20251.845 229 111 60 69 148 230 66 79 280 66 198 309
2025/20264.183 203 495 496 792 369 169 584 211 540 237 87 0
Totale 8.850